• mellitus. The major PDE5 inhibitors (a subset of the phosphodiesterase inhibitors) are sildenafil, tadalafil, vardenafil, and avanafil, and although all share...
    42 KB (4,750 words) - 00:42, 24 August 2023
  • Thumbnail for Phosphodiesterase inhibitor
    A phosphodiesterase inhibitor is a drug that blocks one or more of the five subtypes of the enzyme phosphodiesterase (PDE), thereby preventing the inactivation...
    22 KB (2,348 words) - 07:30, 22 April 2024
  • Thumbnail for PDE5 inhibitor
    hypertension. As of 2019, the wider cardiovascular benefits of PDE5 inhibitors are being appreciated. Phosphodiesterase-5 (PDE5) inhibitors such as sildenafil...
    16 KB (1,721 words) - 14:51, 11 March 2024
  • Thumbnail for Phosphodiesterase-4 inhibitor
    A phosphodiesterase-4 inhibitor, commonly referred to as a PDE4 inhibitor, is a drug used to block the degradative action of phosphodiesterase 4 (PDE4)...
    18 KB (1,886 words) - 15:58, 11 November 2023
  • Thumbnail for Phosphodiesterase
    potential for selective phosphodiesterase inhibitors to be used as therapeutic agents was predicted in the 1970s by Weiss and coworkers. This prediction...
    14 KB (1,660 words) - 17:53, 12 February 2024
  • Thumbnail for Serotonin–norepinephrine reuptake inhibitor
    disorder (OCD), and migraine prevention. SNRIs are monoamine reuptake inhibitors; specifically, they inhibit the reuptake of serotonin and norepinephrine...
    78 KB (7,687 words) - 09:12, 6 April 2024
  • Phosphodiesterase 1, PDE1, EC 3.1.4.1, systematic name oligonucleotide 5′-nucleotidohydrolase) is a phosphodiesterase enzyme also known as calcium- and...
    22 KB (2,560 words) - 15:24, 27 September 2023
  • Thumbnail for Enzyme inhibitor
    the enzyme's catalysis of the reaction is blocked. Enzyme inhibitors may bind reversibly or irreversibly. Irreversible inhibitors form a chemical bond with...
    104 KB (11,575 words) - 10:05, 2 March 2024
  • Thumbnail for CYP3A4
    CYP3A4 (redirect from CYP3A4 inhibitors)
    20–50% decrease in clearance. The inhibitors of CYP3A4 are the following substances. boceprevir, protease inhibitors: ritonavir, indinavir, nelfinavir...
    80 KB (7,730 words) - 12:02, 2 May 2024
  • Thumbnail for Cereblon E3 ligase modulator
    and the forms imide, imido-, imid-, and imid. The development of analogs of thalidomide was precipitated by the discovery of the anti-angiogenic and anti-inflammatory...
    49 KB (5,487 words) - 11:41, 24 January 2024
  • the first JAK inhibitor, ruxolitinib, to treat a skin condition. Some JAK1 inhibitors are based on a benzimidazole core. JAK3 inhibitors target the catalytic...
    35 KB (2,858 words) - 16:20, 9 May 2024
  • Thumbnail for Sildenafil
    Sildenafil (category PDE5 inhibitors)
    "Recreational use and misuse of phosphodiesterase 5 inhibitors". Journal of the American Pharmacists Association. 45 (1): 63–72, quiz 73–5. doi:10.1331/1544345052843165...
    70 KB (6,742 words) - 14:09, 3 May 2024
  • reactions, and systemic side effects. The global market for TNF inhibitors in 2008 was US$13.5 billion and US$22 billion in 2009. Inhibition of TNF effects...
    33 KB (3,686 words) - 07:30, 20 May 2024
  • Thumbnail for Theophylline
    Theophylline (category Phosphodiesterase inhibitors)
    drug that inhibits phosphodiesterase and blocks adenosine receptors. It is used to treat chronic obstructive pulmonary disease (COPD) and asthma. Its...
    24 KB (2,233 words) - 16:40, 28 April 2024
  • Thumbnail for PDE10A
    PDE10A (redirect from Phosphodiesterase 10A)
    JF, Hou X, et al. (August 2009). "Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate...
    10 KB (1,035 words) - 22:06, 27 March 2024
  • Thumbnail for Cyclic guanosine monophosphate
    -11 can hydrolyse both cAMP and cGMP. Phosphodiesterase inhibitors prevent the degradation of cGMP, thereby enhancing and/or prolonging its effects. For...
    11 KB (1,122 words) - 01:24, 20 February 2024
  • the airways. Prior to their discovery, the non-selective beta-agonist isoprenaline was used. The aim of the drug development through the years has been...
    29 KB (3,066 words) - 03:32, 20 October 2023
  • Thumbnail for Tadalafil
    Tadalafil (category PDE5 inhibitors)
    (February 2020). "Risk of nonarteritic ischaemic optic neuropathy with phosphodiesterase type 5 inhibitors: a systematic review and meta-analysis". Acta...
    36 KB (3,238 words) - 06:08, 28 March 2024
  • adenylyl cyclase caffeine and theophylline inhibit cAMP phosphodiesterase, which degrades cAMP - thus enabling higher levels of cAMP than would otherwise...
    11 KB (1,386 words) - 01:44, 28 March 2024
  • Thumbnail for Mardepodect
    Mardepodect (category Phosphodiesterase inhibitors)
    et al. (August 2009). "Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4...
    6 KB (395 words) - 19:59, 20 December 2023
  • Thumbnail for Rolipram
    Rolipram (category PDE4 inhibitors)
    Rolipram is a selective phosphodiesterase-4 inhibitor discovered and developed by Schering AG as a potential antidepressant drug in the early 1990s. It...
    7 KB (542 words) - 18:38, 8 December 2023
  • It was clear that ligands of adenosine receptors and inhibitors for phosphodiesterase were targets for drug development. In 1992, the therapeutic potential...
    18 KB (2,064 words) - 17:48, 23 March 2024
  • Thumbnail for Nitroglycerin (medication)
    and release of vasoconstrictors such as endothelin and angiotensin II. Hypothesis of Munzel et al. (1995).[full citation needed] "Phosphodiesterase Inhibitors"...
    25 KB (2,645 words) - 03:41, 27 February 2024
  • Thumbnail for Mechanism of action
    indications for the drug to be identified. Discovery that sildenafil inhibits phosphodiesterase-5 (PDE-5) proteins, for example, enabled this drug to...
    17 KB (1,849 words) - 11:51, 25 December 2023
  • Examples of drugs that are transition state analog inhibitors include flu medications such as the neuraminidase inhibitor oseltamivir and the HIV protease...
    12 KB (1,363 words) - 03:36, 27 October 2023
  • Adenosine diphosphate (ADP) receptor inhibitors are a drug class of antiplatelet agents, used in the treatment of acute coronary syndrome (ACS) or in preventive...
    46 KB (5,282 words) - 08:16, 30 March 2024
  • Benjamin Weiss (scientist) (category Wikipedia articles with possible conflicts of interest from May 2021)
    selective inhibition of phosphodiesterases which are expressed differentially in all tissues, could be used as a target for drug development. His work is the...
    26 KB (3,164 words) - 05:14, 3 August 2023
  • Thumbnail for 3T3-L1
    3T3-L1 (section Discoveries)
    3T3-L1 cells through the addition of compounds such as a synthetic glucocorticoid, a phosphodiesterase inhibitor, and insulin. The most commonly used synthetic...
    17 KB (1,907 words) - 21:39, 15 April 2024
  • Thumbnail for Antidepressant
    serotonin reuptake inhibitors (SSRIs) or norepinephrine reuptake inhibitors, while a person suffering from loss of energy and enjoyment of life would take...
    190 KB (20,467 words) - 02:58, 12 May 2024
  • Thumbnail for Caffeine
    Caffeine (redirect from Caffeine and Health)
    inhibition of phosphodiesterase. Caffeine is a bitter, white crystalline purine, a methylxanthine alkaloid, and is chemically related to the adenine and guanine...
    199 KB (19,813 words) - 21:52, 17 May 2024